Home

elveszít Depresszió Beágyaz r ipi lead Gyakran beszélnek furfangos

The Enhanced International Prognostic Index for Diffuse Large B‐cell  Lymphoma | Semantic Scholar
The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma | Semantic Scholar

Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for  patients with diffuse large B-cell lymphoma treated in the rituximab era. |  Semantic Scholar
Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma. - ppt download
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download

The Revised International Prognostic Index (R-IPI) Score Is Predictive Of  Survival In Aggressive Transformed Lymphomas (TL) From Low Grade  Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect
The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma. - ppt download
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download

Frontiers | Development and Validation of a Novel Risk Stratification Model  for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma treated with R-CHOP - ScienceDirect
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP - ScienceDirect

PPT - Journal reading PowerPoint Presentation, free download - ID:5961950
PPT - Journal reading PowerPoint Presentation, free download - ID:5961950

Outcome prediction of diffuse large B-cell lymphomas associated with  hepatitis C virus infection: a study on behalf of the Fondazione Italiana  Linfomi | Haematologica
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi | Haematologica

Progression free survival (A) and overall survival (B) stratified by... |  Download Scientific Diagram
Progression free survival (A) and overall survival (B) stratified by... | Download Scientific Diagram

A prognostic index predicting survival in transformed Waldenström  macroglobulinemia | Haematologica
A prognostic index predicting survival in transformed Waldenström macroglobulinemia | Haematologica

Time of relapse after initial therapy significantly adds to the prognostic  value of the IPI-R in patients with relapsed DLBCL undergoing autologous  stem cell transplantation | Bone Marrow Transplantation
Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation | Bone Marrow Transplantation

Table 2 from The revised International Prognostic Index (R-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar

Distribution of patients inside risk groups and OS by standard IPI [8],...  | Download Table
Distribution of patients inside risk groups and OS by standard IPI [8],... | Download Table

MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar

Revised International Prognostic Index (R-IPI) Is a Better Predictor of  Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell  Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP). - ScienceDirect
Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP). - ScienceDirect

Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and  NCCN‑IPI in patients with diffuse large B‑cell lymphoma
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma

Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to  Management?
Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to Management?

Outcome according to the revised International Prognostic Index (R-IPI)...  | Download Scientific Diagram
Outcome according to the revised International Prognostic Index (R-IPI)... | Download Scientific Diagram

Revised International Prognostic Index (R-IPI): Tool for Predicting  Outcomes in DLBCL
Revised International Prognostic Index (R-IPI): Tool for Predicting Outcomes in DLBCL

A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell  Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and  Lymphocyte Counts Is Absent | PLOS ONE
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent | PLOS ONE

Distribution of patients inside risk groups and OS by standard IPI [8],...  | Download Table
Distribution of patients inside risk groups and OS by standard IPI [8],... | Download Table

Extracting Randomness from the Trend of IPI for Cryptographic Operations in  Implantable Medical Devices – RISS
Extracting Randomness from the Trend of IPI for Cryptographic Operations in Implantable Medical Devices – RISS

A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell  Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and  Lymphocyte Counts Is Absent | PLOS ONE
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent | PLOS ONE

International prognostic indices in diffuse large B-cell lymphoma: a  comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect

International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting  Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding  Serum Albumin As Another Predictive Factor. Retrospective Study of the  Mexican Study
International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding Serum Albumin As Another Predictive Factor. Retrospective Study of the Mexican Study

Table 2 from The revised International Prognostic Index (R-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar